Recorded Chinese product: 吡诺克辛滴眼液吡诺克辛滴眼液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司
主要成分Active Ingredients
- 吡诺克辛Binuo Kexin
药物知识说明
吡诺克辛是一种在国家药监局注册认定的药品。标注生产企业为湖北远大天天明制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司、湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司、湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 吡诺克辛滴眼液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 湖北远大天天明制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司, 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司, 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 吡诺克辛滴眼液Recorded Chinese product: 吡诺克辛滴眼液
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 0.005%(5ml:0.25mg)0.005 %(5 mL:0.25 mg)
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 湖北远大天天明制药有限公司Chinese legal name: 湖北远大天天明制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20113487
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20113487
Manufacturer
Chinese legal name: 湖北远大天天明制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20113487
生产企业
湖北远大天天明制药有限公司(国产)
适应症
本品用于初期老年性白内障。
用法用量
用前请充分摇匀，1次1～2滴，1日3～5次滴于眼内。
不良反应
1. 过敏症：可能会发生眼睑炎、接触性皮炎。
2. 眼：可能会发生弥漫性浅表性角膜炎、结膜充血、刺激感、瘙痒感。尚未对包括不良反应发生频率在内的本品使用情况进行明确的调查，当出现不良反应时应采取停止用药等适当的处置。
禁忌
对本品任何成分过敏者禁用。
注意事项
1. 给药途径：仅用于滴眼。
2. 使用方法：为了防止污染药液，滴眼时应注意避免容器的前端直接接触眼部。
贮藏
密封容器，1-30摄氏度保存。
规格
0.005%(5ml:0.25mg)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.